Silberman David 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Sep 2, 2021
Insider Transaction Report
Form 4
Silberman David
Chief Financial Officer
Transactions
- Award
Common Stock
2021-09-01+50,000→ 50,000 total - Award
Stock Option (right to buy)
2021-09-01+50,000→ 50,000 totalExercise: $20.19Exp: 2031-09-01→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Represents common stock underlying Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The RSUs will vest as follows: 33,333 shall vest in three equal installments over a period of three years upon Issuer's common stock achieving a specified price per share, and 16,667 shall vest in three equal installments over a period of three years upon Issuer's achievement of certain business objectives.
- [F3]The Stock Options will vest in four equal installments of 12,500 on each of June 27, 2022, June 27, 2023, June 27, 2024 and June 27, 2025.